Bad Bugs, ‘New’ Drugs: Updates on Antibiotic Treatment Options for Multidrug-Resistant Gram-Negative Bacterial Infections Webcast is organized by AchieveCE.
Activity Release Date: April 8, 2022
Activity Expiration Date: April 8, 2025
Activity Overview:
Antibiotic-resistant bacteria are a major problem both nationally and globally. Novel antibiotic options are being developed for the treatment of multidrug-resistant Gram-negative bacterial infections.
This activity is intended to make pharmacists, pharmacy technicians, and nurses aware of these novel antibiotics to recognize their potential clinical utility, pharmacology, adverse effects, and clinical pearls as well as evaluate available literature on their use for the treatment of such infections.
Pharmacist Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Review common resistance mechanisms among Gram-negative bacteria
• Describe novel antibiotic agents based on their pharmacological properties and spectrum of activity
• Evaluate the role of novel antibiotic agents in the treatment of multidrug-resistant gram-negative bacterial infections based on emerging clinical data
Pharmacy Technician Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Review common resistance mechanisms among Gram-negative bacteria
• List novel antibiotic agents based on their pharmacological properties and spectrum of activity
• Review literature on how novel antibiotic agents affects multidrug-resistant Gram-negative bacterial infections
Nurse Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Review common resistance mechanisms among Gram-negative bacteria
• List novel antibiotic agents based on their pharmacological properties and spectrum of activity
• Review literature on how novel antibiotic agents affects multidrug-resistant Gram-negative bacterial infections.